Boyle Kevin S. Sr. 4
4 · Alaunos Therapeutics, Inc. · Filed Sep 1, 2022
Insider Transaction Report
Form 4
Boyle Kevin S. Sr.
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2022-08-30$2.41/sh−18,750$45,188→ 866,250 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligations in connection with the vesting of shares of restricted stock previously granted to the Reporting Person.